Results
35
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
35 companies
Novartis
Market Cap: CHF 189.7b
Engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally.
NOVN
CHF 96.80
7D
0.8%
1Y
-0.5%
Merck
Market Cap: US$203.2b
Operates as a healthcare company worldwide.
MRK
US$80.93
7D
2.7%
1Y
-35.7%
Waters
Market Cap: US$20.8b
Provides analytical workflow solutions in Asia, the Americas, and Europe.
WAT
US$350.22
7D
-1.3%
1Y
21.8%
Exelixis
Market Cap: US$12.6b
An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.
EXEL
US$46.15
7D
7.1%
1Y
110.2%
Orion Oyj
Market Cap: €8.7b
Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.
ORNBV
€62.10
7D
-0.7%
1Y
49.7%
Abbott India
Market Cap: ₹754.0b
Operates as a pharmaceutical company in India.
500488
₹34,746.45
7D
-0.7%
1Y
24.8%
GlaxoSmithKline Pharmaceuticals
Market Cap: ₹558.8b
Manufactures, distributes, and trades in pharmaceuticals in India and internationally.
500660
₹3,285.70
7D
-5.0%
1Y
29.6%
SK Biopharmaceuticals
Market Cap: ₩7.3t
A pharmaceutical company, engages in the research and development of drugs for the treatment of central nervous system disorders.
A326030
₩91,200.00
7D
-0.1%
1Y
15.4%
Xiamen Amoytop Biotech
Market Cap: CN¥29.4b
Engages in research, development, production, and sale of recombinant protein drugs in China.
688278
CN¥71.90
7D
-0.3%
1Y
32.5%
Agios Pharmaceuticals
Market Cap: US$2.1b
A biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States.
AGIO
US$36.07
7D
7.2%
1Y
-14.2%
BioArctic
Market Cap: SEK 16.2b
Develops biological drugs for patients with central nervous system disorders in Sweden.
BIOA B
SEK 182.70
7D
3.5%
1Y
-17.2%
Sanofi India
Market Cap: ₹140.5b
Manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally.
500674
₹6,086.85
7D
-1.6%
1Y
-7.5%
Neuren Pharmaceuticals
Market Cap: AU$1.8b
A biopharmaceutical company, develops drugs for the treatment of neurological disorders.
NEU
AU$14.28
7D
0.6%
1Y
-28.5%
Procter & Gamble Health
Market Cap: ₹97.2b
Engages in the manufacture and marketing of pharmaceuticals and chemical products in India and internationally.
500126
₹5,760.55
7D
-2.7%
1Y
11.1%
Philogen
Market Cap: €847.0m
A biotechnology company, develops drugs for oncology and chronic inflammatory diseases.
PHIL
€21.00
7D
-7.1%
1Y
1.0%
Jeena Sikho Lifecare
Market Cap: ₹60.5b
Trades in ayurvedic medicines in India.
JSLL
₹525.35
7D
23.8%
1Y
136.4%
L&C BIOLTD
Market Cap: ₩726.3b
L&C Bio Co., Ltd operates as a research and development company in tissue regeneration medicine.
A290650
₩29,750.00
7D
6.8%
1Y
22.4%
RPG Life Sciences
Market Cap: ₹41.4b
An integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally.
RPGLIFE
₹2,519.90
7D
5.0%
1Y
54.8%
Ever Supreme Bio Technology
Market Cap: NT$13.6b
Engages in the research, development, and manufacture of drug products related to human mesenchymal stem cells and immune cells in Taiwan.
6712
NT$152.50
7D
-2.2%
1Y
-15.3%
PharmaEngine
Market Cap: NT$11.3b
A biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan.
4162
NT$76.10
7D
-3.7%
1Y
-21.9%
China SXT Pharmaceuticals
Market Cap: US$218.1m
A pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China.
SXTC
US$1.88
7D
8.0%
1Y
-77.6%
Puma Biotechnology
Market Cap: US$177.7m
A biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally.
PBYI
US$3.58
7D
8.2%
1Y
18.5%
NATURLAND Holding Vagyonkezelo es Befektetesi Nyilvanosan Mukodo Reszvenytarsasag
Market Cap: Ft35.9b
Manufactures and sells pharmaceutical products in Hungary.
NATURLAND
Ft2,600.00
7D
2.4%
1Y
6.6%
Ind-Swift Laboratories
Market Cap: ₹6.8b
Develops, manufactures, and sells active pharmaceutical ingredients (APIs), intermediates, and formulations in India and internationally.
INDSWFTLAB
₹114.04
7D
3.9%
1Y
-14.5%
EZZ Life Science Holdings
Market Cap: AU$105.2m
Engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and internationally.
EZZ
AU$2.29
7D
-0.4%
1Y
35.9%
JW Shinyak
Market Cap: ₩89.2b
Engages in the research, development, production, and sale of medicines and medical supplies in South Korea.
A067290
₩1,647.00
7D
1.6%
1Y
1.1%
Kahira Pharmaceuticals & Chemical Industries
Market Cap: ج.م2.7b
Engages in the manufacturing and sale of pharmaceuticals, medical preparations, cosmetics, and materials in Egypt.
CPCI
ج.م179.17
7D
4.3%
1Y
161.8%
Alexandria For Pharmaceuticals & Chemical Industries
Market Cap: ج.م2.2b
Manufactures, markets, and distributes generic forms of human and animal health products in Egypt.
AXPH
ج.م447.45
7D
6.3%
1Y
112.4%
Pharmedic Pharmaceutical Medicinal
Market Cap: ₫979.9b
Engages in the manufacture and trade of pharmaceutical products, medicinal materials, cosmetics, medical supplies, and other products in Vietnam.
PMC
₫105,500.00
7D
-4.9%
1Y
20.6%
Influx Healthtech
Market Cap: ₹2.9b
Operates as a contract development and manufacturing organization that provides a range of healthcare products in India.
INFLUX
₹131.35
7D
-2.3%
1Y
n/a
Arab Drug
Market Cap: ج.م1.2b
Engages in the manufacture and sale of pharmaceutical products.
ADCI
ج.م199.13
7D
-1.9%
1Y
142.8%
Celemics
Market Cap: ₩25.5b
Designs, manufactures, and distributes sequencing kits in South Korea.
A331920
₩3,065.00
7D
0.8%
1Y
-12.4%
Genesis IBRC India
Market Cap: ₹275.9m
Does not have significant operations.
514336
₹21.22
7D
5.0%
1Y
47.5%
Scinai Immunotherapeutics
Market Cap: US$2.1m
A biopharmaceutical company, focuses on developing, manufacturing, and commercializing inflammation and immunology biological products for the treatment of infectious and autoimmune diseases in Israel.
SCNI
US$2.20
7D
-10.8%
1Y
-29.5%
Captor Capital
Market Cap: CA$1.5m
Engages in the retail sale of cannabis products in the United States.
CPTR
CA$0.43
7D
0%
1Y
43.3%